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Abstract
The increasing number of older adults with blood-related disorders and the introduction of reduced 
intensity conditioning regimens has led to increases in hematopoietic stem cell (HSC) 
transplantation among older adults and a corresponding increase in the age of siblings who donate 
HSCs to these patients. Data regarding the donation-related experiences of older donors is lacking. 
The Related Donor Safety Study (RDSafe) aimed to examine/compare health-related quality of 
life (HRQoL) of older versus younger HSC donors. 60 peripheral blood stem cell (PBSC) donors 
ages 18–60 and 104 PBSC donors age >60 completed validated questionnaires at pre-donation, 4 
weeks and 1 year post-donation. Prior to donation, older donors had poorer general physical health 
(t=−3.27; p=.001) but better mental health (t=2.11; p<.05). There were no age differences in 
multiple other donation-related factors. At 4 weeks post-donation, there were no group differences 
in general physical/mental health, but older donors were less likely to report donation-related pain 
(t=−2.26; p<.05) and concerns (t=−3.38; p=.001). At both 4 weeks and 1 year post-donation, there 
were no significant differences in the percentage of each age group feeling physically back to 
normal or in the number of days it took donors to feel completely well. There was no evidence that 
increasing age within the older donor group was associated with poorer donation-related HRQoL. 
Taken together, these data support the current practice of HSC donation by sibling donors above 
age 60, providing no evidence of worsening HRQoL up to one year after donation in individuals 
up to age 76.
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INTRODUCTION
Hematopoietic stem cell (HSC) transplantation is increasingly used to treat leukemia and 
other blood-related diseases for which other forms of therapy are ineffective or would be less 
effective. Several factors, including the increasing number of older adults as a proportion of 
the population, the introduction of reduced intensity conditioning regimens and improved 
supportive care have made HSC transplantation an increasingly utilized therapy for older 
adults.1–3 In the decade from 2000–2011, the number of HSC transplants for patients >60 
years of age quadrupled and continues to increase.1 The increasing age of transplant patients 
has led to a parallel increase in the average age of sibling HSC donors enlisted to help these 
patients.1 This has raised questions about whether grafts from older donors are equally 
effective for patients as those from younger donors and whether the donation process is safe 
for this group of donors.
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In terms of the effectiveness of HSCs from older donors, there is mounting evidence that 
older donors can produce high quality grafts, and several studies have found that advanced 
donor age does not produce poorer outcomes for patients.4–7 Rezvani found (a) no difference 
between donors <60 and those ≥60 in terms of HSC engraftment, the pace of neutrophil and 
platelet recovery and donor chimerism, and (b) no increased risk of donor-derived clonal 
disorders from stem cells of older donors.3
Studies focused on the safety and donation-related experiences of older sibling donors are 
less common.1 Some evidence that older donor age may be associated with an increased 
number of adverse events has lead most international registries to set upper age limits for 
unrelated donors of 60 years or younger. 8,9 Many of these registries have also recently 
revised the upper age limit for joining a registry downward to 40–although this is primarily 
due to better patient outcomes when younger donors are used rather than donor safety 
concers.10–12 No such guidelines exist for related donors, and an aging population, the 
increasing use of haploidentical transplantation, and improvements in transplant-related 
regimens make it likely that the use of older sibling donors will continue to increase. Despite 
this, there are no existing large systematic investigations of health-related quality of life 
(HRQoL) in the context of older related HSC donation.
The goal of the current investigation was to examine and compare the donation-related 
experiences and health-related quality of life (HRQoL) of older versus younger sibling HSC 
donors. This investigation was part of a larger study (NHLBI-funded Related Donor Safety 
Study, RDSafe) focused on the medical safety and HRQoL of related HSC donation. The 
specific aims of the sub-study focused on HRQoL of older donors were to (a) longitudinally 
examine HRQoL among HSC donors >60 years of age from pre-donation through one year 
post-donation, (b) compare HRQoL of older donors with those of their younger counterparts 
aged 18–60, and (c) to examine whether increasing age within the group of donors >60 was 
associated with poorer donation-related HRQoL.
MATERIALS AND METHODS
Human subjects research protection
This investigation was approved by the Institutional Review Boards at the University of 
Pittsburgh, the National Marrow Donor Program (NMDP), and individual transplant centers 
when required. All participants signed informed consent before completing the study 
interviews.
Participants and study design
This prospective, longitudinal investigation included adult related HSC donors ages 18–76, 
enrolled in the parent RDSafe investigation who donated PBSC at one of 41, geographically 
diverse, US transplant centers between 03/2010 and 04/2013 (see supplement table for a list 
of contributing centers). The number of donors contributed by center ranged from 1–20 with 
a median of 3 donors per center.
To be eligible, potential participants were required to meet the requirements for donation at 
each transplant center and consent to participate in both the parent RDSafe study and the 
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donor HRQoL sub-study. Potential participants were excluded from the study if they did not 
read, write, and speak English, were unable to complete a telephone interview due to 
cognitive or linguistic difficulties, or if they did not have access to a telephone.
Individual transplant centers consented participants for the study and passed contact 
information of enrolled donors to University of Pittsburgh staff. Interviewers from the 
University of Pittsburgh contacted participants by telephone to complete data collection. 
Within four weeks prior to initiation of G-CSF administration for PBSC donors, participants 
completed a baseline interview. All donors were interviewed again 4 weeks and 1 year after 
donation. The interviews required approximately 20 minutes to complete and participants 
received a $25 honorarium after completing each interview. A Computer Assisted Telephone 
Interview (CATI) system was used to collect and enter interview data. Data were stored on a 
secure server in an encrypted data file.
Study measures
Three categories of participant characteristics were assessed: (1) socio-demographic, (2) 
general physical and psychological status, and (3) donation-related. Measures were 
previously validated scales/items with established measurement properties either created for, 
or used in, other donation-related settings. Recipient status at 1 year following donation was 
collected directly from transplant center records.
Socio-demographic characteristics: sex, age, race/ethnicity, education level, employment 
status, income, marital status, whether the donor had children, and whether he/she had ever 
donated blood or apheresis. For the analysis examining HRQoL by age groupings within the 
older donor group, age was trichotomized 61–64, 65–69, and ≥70.
General physical and psychological status—Overall/generic physical and 
psychological status were assessed with the physical and mental health summary scales of 
the SF12v2.13 Scores range from 0–100 with higher scores indicating better physical/mental 
health. Anxiety and depression were assessed with the anxiety and depression subscales of 
the Brief Symptom Inventory (BSI). Each subscale consisted of 6 items which were 
averaged to create a score ranging from 0–4. Higher scores indicate greater emotional 
distress. 14,15
Donation-related—At all three interview time points: Ambivalence about the decision 
of whether or not to donate was assessed with the 7-item Ambivalence scale.16–19 Items 
were averaged–a higher score indicates greater uncertainty/reluctance about donation. 
Satisfaction with the donation decision was assessed with two items asking about overall 
satisfaction and happiness with the decision (1=not at all; 4=extremely).20 Perceived risk of 
donation was assessed with three items asking about the likelihood of a serious donation-
related complication (1=not at all likely; 4=very likely), likelihood that a donor could feel 
sad or let down following donation (1=not at all likely; 4=very likely), and the likelihood 
that a donor could feel responsible if the recipient did not survive (1=strongly disagree; 
4=strongly agree).20 At pre-donation and 4-weeks post-donation: Concerns about 
donation were assessed with 11 concerns summed across three categories –medical, work/
family, and other (yes/no).19–21 Interactions with others was assessed with four items asking 
Switzer et al. Page 4













whether donors consulted family/friends or professionals about donation and whether they 
had been encouraged/discouraged from donating (yes/no).19,20 At 4-weeks and 1 year post-
donation: Physical effects of donation were assessed with 5 items asking about the physical 
experience of donation including donation-related pain (1= a lot less painful than expected; 
5=much more painful than expected), whether the donor had a fever (yes/no), whether the 
donor currently felt back to normal following donation (yes/no), the number of days 
following donation until they felt completely well, and their use of prescription and 
nonprescription medications (yes/no).19 Current symptoms assessed as present/absent in the 
previous 48 hours included tiredness, problems sleeping, muscle aches, bone pain, difficulty 
walking, light headedness, bleeding, pain where the needles were inserted, chills, fainting, 
nausea, and infection.21 Psychological effects of donation were assessed with 3 items 
including stressfulness of donation (1=not at all stressful; 4=very stressful), concern about 
their own current health as a result of donation (1=not at all worried; 4=very worried), or the 
longer-term effects of donation (1=definitely will not have impact; 4=definitely will have 
impact).19,21 At 1 year post-donation: Recipient status for each related donor (alive/
deceased) was assessed at 1 year post-donation.
Statistical analysis
Data were cleaned and exported from the CATI system to IBM SPSS Statistics for Windows, 
Version 22.0 (IBM Corporation, Armonk, NY, USA) for analysis. Cross-sectional 
differences in donor HRQoL by age group at each key time point were examined using 
odds-ratios for categorical variables and t-tests for continuous variables. To examine 
longitudinal differences in physical and mental health (SF12v2 physical and mental health 
summary scores) by age group, we used linear mixed models analyses. Main effects for age 
group and time and the age group by time interactions were examined. Oneway Analysis of 
Variance (ANOVA) was used to examine differences across the 3 age groups of older donors 
(61–64, 65–69, and ≥70). Generalized linear models were used to examine differences in key 
HRQoL variables by age and recipient status.
RESULTS
Participants
Donors were randomly selected for the HRQoL study from the eligible pool of potential 
participants in the larger RDSafe study with the goal of reaching target samples of ~100 in 
each of the older and younger related donor age groups. The final sample included 119 
donors ages 18–60 and 104 donors ages >60. Because all the older donors donated PBSC, 
only the younger donors who donated PBSC (N=60) were used as a comparator. Completion 
rates by cross-sectional time point for younger and older donors respectively were; pre-
donation, 91%/92%, 4-weeks post-donation, 90%/92% and 1-year post-donation, 84%/88%. 
A total panel of 142 (87%) completed all three interviews. Results from the panel with 
complete data were identical to those for the full sample– results presented here are based on 
all data from all time points.
Pre-donation—As would be expected, older donors were less likely to be employed 
(OR=0.14; p<.001) and more likely be white (OR=3.21; p<.01), married (OR=2.06; p<.05), 
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and to have children (OR=5.26; p<.001; Table 1). Prior to donation, older donors had poorer 
general physical health (t=−3.27; p=.001) but better general mental health (t=2.11; p<.05). 
There were no age differences in anxiety, depression, ambivalence about donation, 
satisfaction with the donation decision, medical concerns about donation or perceived risks 
of donation. Older donors were more likely to consult their personal physician about 
donation (OR=1.96; p<.05) but had fewer work/family concerns (t=−1.99; p<.05).
Four weeks post-donation—At 4 weeks post-donation, there were no age group 
differences in general physical or mental health, ambivalence/satisfaction with the donation 
decision, 12 donation-related symptoms, or in psychological effects of donation (Table 2). 
Older donors were less likely to report donation-related pain (t=−2.26; p<.05), and other 
concerns about the donation process (t=−2.14; p<.05)–particularly less concern about who 
would pay for the procedure. They continued after donation to have fewer work/family 
concerns about the donation process (t=−3.38; p=.001). Older donors were also less likely to 
report the risk of feeling responsible if the recipient did not survive (t=−2.31; p<.05). There 
were no statistically significant age group differences in the percentage of each group 
reporting feeling physically back to normal (younger=91%; older=85%), or in the number of 
days it took donors to feel completely well following donation among those who reported 
full recovery (p=.196).
One year post-donation—At 1 year post-donation, there were no differences between 
older and younger donors in overall physical and mental health as assessed with the 
SF-12v2–although older donors reported significantly less anxiety than did younger donors 
(t=−2.49; p<.05; Table 3). Older donors continued to be less likely to report the risk of 
feeling responsible if the recipient did not survive (t=−2.27; p<.05). There was no difference 
in the percentage of donors reporting feeling completely back to normal, and no difference 
in number of days to recovery (t=1.22; p=.23; median recovery for both groups was 7 days). 
Fifteen and 16% respectively of the older and younger groups reported recovery periods of 
longer than 30 days and 3% and 8% respectively reported not being recovered by one-year 
post-donation. Older donors reported fewer current problems sleeping (OR=0.40; p<.05) but 
did not differ from younger donors on any other symptoms or in concern about longer-term 
donation effects. Recipient status (alive versus deceased) did not differ by donor age group.
Group comparisons of key variables for three groups of older donors—Within 
the older donor group (age >60), age was trichotomized 61–64 (N=49), 65–69 (N=39), and 
70+ (N=16) and the three groups were compared on key general physical/mental health and 
days to full recovery assessed at 1 year post-donation. In terms of basic demographic 
characteristics, the three age groups did not differ significantly in gender representation 
(range = 51%–56% female), race/ethnicity (range 90%–94% White), education (range = 
31%–51%≥Bachelor’s degree), or marital status (range 76%–81% married). At pre-
donation, the middle age group (65–69) had better general mental health (F=4.03; df=2,101, 
p<.05; Table 4) and less depression (F=4.95; df=2,101, p<.01) compared to the other two 
age groups. There were no significant age group differences in general physical/mental 
health at either of the post-donation assessment time points. Age groups did not differ 
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significantly in the number of days to full recovery (F=1.03; df=2,89, p=.36; age=61–64, 
median=7 days; age=65–69, median=7 days; age=70–76, median=10.5 days).
DISCUSSION
This is the first large systematic investigation of HRQoL among older, related HSC donors. 
The central goal of this investigation was to examine the HRQoL and donation-related 
experiences of sibling HSC donors >60 years of age and to compare them to those of their 
younger adult counterparts. Our overall conclusion is that there were few differences in 
donation-related experiences between older donors in this study and a younger donor 
comparison group.
At pre-donation there were a few, anticipated, demographic differences between older and 
younger donors–older donors were more likely to be white, married, and to have children. 
Also not surprisingly, older donors reported significantly poorer general physical health but 
better mental health than their younger counterparts. These findings reflect trends in the 
general population that suggest that while aging produces physical declines, it may also be 
associated with better mental health including lower distress/depression levels and greater 
happiness.22–24 The older and younger donor groups did not differ in their view of the 
donation process including satisfaction with the decision to donate, ambivalence about 
donation, and perceived risks of donating although older donors did have fewer donation-
related concerns related to work and family.
At 4 weeks post-donation–the point at which we might have expected any differences in the 
physical experience of donation to be most likely to be reported–older and younger donors 
did not differ in overall physical/mental health, current symptom levels, the percent that felt 
back to normal following donation, or the number of days until they felt completely well 
following donation. Older donors did report less donation-related pain, fewer family/work 
concerns, and less perceived responsibility if the transplant was not successful for the 
patient.
A similar pattern was evident at one-year post-donation–there were few age-related 
differences in indicators of physical and mental health, although older donors did report 
significantly less anxiety than their younger counterparts. At one year, there was no 
difference in recovery periods following donation (median=7 for both groups).
Finally, there is no evidence from this investigation that advancing age within the older 
donor group is associated with poorer post-donation physical or mental health. The recovery 
time for the three older age groups did not differ significantly.
There are some characteristics of this investigation and the study population that are 
important to note. First, older donors in this study were selected by transplant centers based 
on their physical health and the likelihood that they would be able to withstand the rigors of 
the donation process. It is therefore likely that they are healthier than their similarly-aged 
counterparts in the general population. A comparison of SF12v2 physical health summary 
scores of older donors to published norms for similarly aged groups seems to support this 
conclusion. The pre-donation physical health summary mean for our cohort of donors aged 
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60–69 was 52.95 versus 44 for a similarly aged normative population cohort and 52.76 
versus 40 for our donor cohort aged 70–79 and an age-matched population cohort.25 The 
mental health summary scores for donors and age-matched norms were similar. Our findings 
are generalizable only to this selected population of relatively healthy older sibling HSC 
donors. Second, because we did not assess symptoms at pre-donation we are limited in our 
ability to chart changes in symptoms from pre- to post-donation. However, this was not a 
goal of this investigation. Finally, the number of donors in the oldest category ages 70–76 is 
small and will require additional investigation with larger numbers to verify that this group 
has similar donation-related HRQoL compared to their younger counterparts.
With these caveats in mind, our findings clearly indicate that older sibling donors do not 
experience the donation process as significantly more physically or psychologically 
impactful than their younger counterparts and that in some ways their experiences may be 
more positive–e.g., less donation-related pain and fewer concerns about donation. Taken 
together, these findings support the practice of PBSC donation by healthy siblings in their 
sixties, with less conclusive evidence supporting the procedure in sibling donors as old as 
mid-seventies. However, it is clear that further research is needed to examine factors that 
may predict longer recovery among the subset of older donors who had extended recovery 
periods, to increase and evaluate our samples of the oldest group of donors, and to continue 
to monitor the HRQoL of older sibling donors as they are increasingly asked to donate.
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• Donation-related HRQoL among older sibling HSC donors >60 is 
similar to that of their younger counterparts 18–60.
• Among older sibling HSC donors 61–76, there is no evidence that 
increasing age is associated with poorer donation-related HRQoL.
• These data support the current practice of HSC donation by sibling 
donors above age 60, and provide no evidence of worsening HRQoL up 
to one year after donation in this group.
Switzer et al. Page 11













Legend for Tables 1–3
• Broad categories of variables are grouped together under bolded 
headings.
• Main comparisons are between younger (18–60) and older (>60) 
donors.
• Both categorical and continuous variables are included in the tables.
• The far left column indicates whether the data for the variable in the 
row is presented as a percentage (%) or as a mean and standard 
deviation (mean, sd).
• Chi-square and odds-ratios were used to examine differences for 
categorical variables.
• T-tests were used to examine differences for continuous variables.
• Either chi-square or t-values are presented in the fourth column of each 
table.
• P-values presented correspond to chi-square values for categorical and 
t-values for continuous variables.
• Fisher’s exact test was used for comparisons with small cell sizes.
Switzer et al. Page 12
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